BioSpace News Archive

Jazz Pharmaceuticals plc announced that the company will webcast its corporate presentation at the 39th Annual J.P. Morgan Healthcare Conference.

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that management will present a company overview at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 8:20 am ET.

Virios Therapeutics, Inc. announced that Greg Duncan, Chairman and Chief Executive Officer, and R. Michael Gendreau, M.D., Ph.D., Chief Medical Officer, will present a company overview at the H.C. Wainwright Virtual BioConnect Conference, which is taking place January 11 - 14, 2021.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the company’s management is scheduled to present at the 39th Annual J.P. Morgan Virtual Healthcare Conference.

Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2020 fourth quarter financial results after the close of the market on Thursday, February 25th.

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect Conference being held from January 11 – 14, 2021. A webcast of the on-demand presentation will be available on the investor section of the Genocea website at http://ir.

Rite Aid Corporation announced that Heyward Donigan, president and chief executive officer; Jim Peters, chief operating officer and Matt Schroeder, executive vice president and chief financial officer will participate in a fireside chat with investors at the 39th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 11th at approximately 11:40 a.m. ET.

Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that Machelle Sanders and Dr. Andrew C. von Eschenbach have joined the Company’s board of directors.

MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the H.C. Wainwright Bioconnect 2021 Conference which will be available on demand starting on January 11, 2021 at 6:00 am (ET). Interested p

ViewRay, Inc., maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, announced that it has commenced an underwritten public offering of shares of its common stock.